Kidney stones affect over one-tenth of the world’s population. According to GlobalData analysis, the stone management disposables market was worth nearly $600M in 2019 and is expected to grow to $866M by 2028. During the pandemic, the market decreased by 15.8% due to cancellation of elective surgeries and decreased hospital admissions in 2020. The stone management disposables market is expected to grow in the coming years, primarily driven by an increasing number of ureteroscopy procedures.

The available treatment options for management of kidney stones include extracorporeal shock wave lithotripsy (SWL), ureteroscopy, percutaneous nephrolithotomy (PCNL), and conventional open surgery. SWL delivers shock waves to the stone to fragment it. Due to its non-invasive nature, SWL is still considered the first line of treatment for kidney stones in many countries. As optic technology has evolved, it made way for newer technologies such as ureteroscopies with lasers and imaging methodologies to locate and manipulate the stones easily and precisely. Ureteroscopy has surpassed SWL as the most commonly performed surgery in developed countries such as the US, Germany, and Japan. As a result, the disposable devices designed for the ureteroscopy procure, including urological stone extractors, urological access sheaths, urological balloon dilators, urological guidewires, and ureteral catheters, have been widely used. The device volume is expected to be increasing with the rising of ureteroscopy globally.

The stone management disposable devices market had a significant revenue decline in the first half of 2020. North America, which holds 48% of the market, experienced a sudden decline in Q2 due to postponed or cancelled ureteroscopy procedures. Even though elective surgeries have largely resumed, the market is still experiencing a decline compared to last year due to strict COVID-19 regulations and delay in urology surgeries. However, GlobalData expects that the market will be able to show a rebound growth in the upcoming quarters, caused by the clearing of backlog ureteroscopy procedures. Revenue loss recovery is expected to occur by the end of 2021.

The prevalence of nephrolithiasis has been increasing over the last three decades, which is the other driver of the market. The incidence of kidney stones is increasing with an estimated prevalence ranging from 4% to 20% globally. The major reason for the increasing prevalence is multifactorial. Increasing population, lifestyle changes such as dietary habits and lack of physical activity, obesity and underlying chronic conditions, and environmental factors are known to contribute to the formation of stones. Additionally, innovations in disposable devices and improvement in imaging and lithotripsy technology to increase stone-free rates will boost the growth of the stone management market in the future.